Pro-inflammatory cytokines
Cytokine is a collective term for functional proteins produced by cells as messengers. Interleukin (IL) -6 is a multifunctional cytokine that regulates immune responses and induces acute phase response (3). IL-6 may represent critical pathophysiologic inflammatory activities. Overproduction of IL-6 is involved in chronic inflammatory diseases, including atherosclerotic cardiovascular diseases (4). IL-6 has been investigated as a potential biomarker of vascular diseases.
Previous studies have shown that serum IL-6 levels were related to cardiovascular risk factors and coronary heart disease (5). The receptor for IL-6 is also a target of prevention of coronary vascular diseases (6) . Conversely, the relationship between inflammatory markers and myocardial single photon emission computed tomography (SPECT) findings remains somewhat controversial (7) . Annals of Nuclear Cardiology Vol. 
Endothelin-1
Endothelin-1 is a peptide vasomodulator produced by endothelial cells, macrophages and fibroblasts (8) . Endothelin Furthermore, in chronic heart failure myocyte apoptosis may be constantly increased and cardiac troponin tends to be elevated. Circulating troponin concentration is therefore useful for evaluation of severity of heart failure and is used as an index for assessing prognosis. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients.
Impaired coronary flow reserve derived from 82
Rb-PET is associated with elevated troponin and major cardiac events (18) , implicating the important relationship between biomarkers and nuclear cardiology. It is also indicated that the combination of troponin T and myocardial 99m Tc-sestamibi scintigraphy is the best model for early prediction of cardiac events in acute chest pain patients (19) . These studies strongly demonstrated the close association between biomarkers and nuclear cardiology and the combined use of these two modalities are useful tools for diagnosis, risk stratification and predications of clinical events.
Biomarkers of pulmonary arterial hypertension
The Using PET the role of metabolic alterations in the development of a maladaptive right ventricular response in PAH was recently evaluated (24) . Abnormalities in fatty acid metabolism may be detected in the blood and myocardium in human PAH and may serve as biomarkers associated with cardiac steatosis or lipotoxicity.
Future directions
Prevalence of cardiovascular disease is high. Risk stratification using appropriate biomarkers and subsequent risk control are important and useful. With the advancement of new imaging modalities (25) such as coronary artery disease (26, 27) and heart failure (28) new biomarkers are readily available. Combined use of new nuclear cardiology modalities with biomarkers one would establish prevention guidelines and classify subgroups needing effective and efficient treatment intervention. For physicians, the capability to utilize and appropriately interpret these biomarkers is imperative to the care of cardiac patients, particularly as these newer biomarkers become widely used.
